DOCETAXEL SERVYCAL

Docetaxel 20 and 80 mg

Intravenous concentrate solution

Made in Argentina

Sale under filed prescription

QUALI - QUANTITATIVE COMPOSITION:

INJECTABLE DOCETAXEL SERVYCAL 20mg:

Each vial of concentrate DOCETAXEL SERVYCAL 20 mg contains:
Anhydrous DOCETAXEL 20.000 mg
Polysorbate 80 500.000 mg

Each vial of diluent DOCETAXEL SERVYCAL 20 mg contains:
Ethanol 95 % 0.195 ml
Water for injection 1.305 ml

INJECTABLE DOCETAXEL SERVYCAL 80 mg:

Each vial of concentrate DOCETAXEL SERVYCAL 80 mg contains:
Anhydrous DOCETAXEL 80.000 mg
Polysorbate 80 2000.000 mg

Each vial of diluent DOCETAXEL SERVYCAL 80 mg contains:
Ethanol 95 % 0.780 ml
Water for injection 5.220 ml

THERAPEUTIC ACTION:
Docetaxel is a semi-synthetic agent that belongs to the taxoid family with antineoplasic activity.

INDICATIONS
DOCETAXEL SERVYCAL is prescribed for the treatment of advanced or metastatic local breast carcinoma after standard therapy has failed.
Previous therapy should have included antracycline unless it is contraindicated.

DOCETAXEL SERVYCAL is prescribed for the treatment of advanced o metastatic non small cell lung cancer, for whom platinum based chemotherapy has failed.


PRESENTATIONS:
Injectable DOCETAXEL SERVYCAL 20 mg
DOCETAXEL 20 mg
Packages with a vial of concentrate for perfusion and a vial of diluent
Injectable DOCETAXEL SERVYCAL 80 mg
DOCETAXEL 80 mg
Packages with a vial of concentrate for perfusion and a vial of diluent

Keep between 2 ºC and 8 ºC and, protected from bright light.